Memoria Científica INCLIVA 2009

Phase II trial of preoperative irinotecan-cisplatin
followed by concurrent irinotecan-cisplatin
and radiotherapy for resectable locally
advanced gastric and esophagogastric junction
adenocarcinoma.
Rivera F, Galán M, Tabernero J, Cervantes A,
Vega-Villegas ME, Gallego J, Laquente B,
Rodríguez E, Carrato A, Escudero P, Massutí
B, Alonso-Orduña V, Cardenal A, Sáenz A,
Giralt J, Yuste AL, Antón A, Aranda E; Spanish
Cooperative Group for Digestive Tumor
Int J Radiat Oncol Biol Phys. 2009 Dec
1;75(5):1430-6.
Factor de Impacto (JCR 2008): 4,64
Risk factors for recurrence and incontinence
after anal fistula surgery.
Jordán J, Roig JV, García-Armengol J, García-
Granero E, Solana A, Lledó S.
Colorectal Dis. 2009 Feb 7.
Factor de Impacto (JCR 2008): 2,29
Fistulectomy and sphincteric reconstruction
for complex cryptoglandular fistulas.
Roig JV, García-Armengol J, Jordán JC, Moro
D, García-Granero E, Alós R.
Colorectal Dis. 2009 Jul 9.
Factor de Impacto (JCR 2008): 2,29
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined
with LV5-FU) or other irinotecan-based
regimens in oxaliplatin-pretreated metastatic
colorectal cancer in the GERCOR OPTIMOX1
study.
Bidard FC, Tournigand C, André T, Mabro M,
Figer A, Cervantes A, Lledo G, Bengrine-
Lefevre L, Maindrault-Goebel F, Louvet C, de
Gramont A.
Ann Oncol. 2009 Jun;20(6):1042-7.
Factor de Impacto (JCR 2008): 4,94
MEMORIA CIENTÍFICA
Fundación Investigación Hospital Clínico de Valencia
Instituto de Investigación Sanitaria - INCLIVA
ECCO 15: 34th ESMO Multidisciplinary
Congress in Berlin: a step forward to a highquality
global oncology forum.
Cervantes A.
Clin Transl Oncol. 2009 Oct;11(10):629-30.
Choroidal metastases from lung adenocarcinoma.
Martín Martorell P, Marí Cotino JF, Insa A.
Clin Transl Oncol. 2009 Oct;11(10):694-7.
Screening for epidermal growth factor receptor
mutations in lung cancer.
Rosell R, Moran T, Queralt C, Porta R,
Cardenal F, Camps C, Majem M, Lopez-
Vivanco G, Isla D, Provencio M, Insa A,
Massuti B, Gonzalez-Larriba JL,Paz-Ares L,
Bover I, Garcia-Campelo R, Moreno MA,
Catot S, Rolfo C, Reguart N, Palmero R,
Sánchez JM, Bastus R, Mayo C, Bertran-
Alamillo J, Molina MA, Sanchez JJ, Taron
M; Spanish Lung Cancer Group.
N Engl J Med. 2009 Sep 3;361(10):958-67.
Factor de Impacto (JCR 2008): 50,02
[Pancreatic and periampullary tumors: morbidity,
mortality, functional results and longterm
survival].
Sabater L, Calvete J, Aparisi L, Cánovas R,
Muñoz E, Añón R, Roselló S, Rodríguez E,
Camps B, Alfonso R, Sala C, Sastre J,
Cervantes A, Lledó S.
Cir Esp. 2009 Sep;86(3):159-66.
The ideal Lateral Internal Sphincterotomy
(LIS): clinical and endosonographic evaluation
following open and closed internal anal
sphincterotomy.
García-Granero E, Sanahuja A, García-Botello
SA, Faiz O, Esclápez P, Espí A, Flor B,
57
Actividad Científica Líneas priorizadas de Investigación